Article
Current and emerging drug treatment strategies for polycystic ovary syndrome.
Expert opinion on pharmacotherapy - 1 Jan 2023
Helvaci Nafiye, Yildiz Bulent Okan
Abstract excerpt
INTRODUCTION: Polycystic ovary syndrome (PCOS) is a common hormonal, metabolic, and reproductive disorder with a heterogeneous phenotype. As the exact etiology of PCOS is still unclear, available pharmacotherapies are mostly directed toward alleviating symptoms and associated metabolic abnormalities. AREAS COVERED: Herein, we present an overview of the current and emerging pharmacotherapies for the management of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
